Kit ELISA sandwich PGRPs/PGLYRP1 (human): quantitative determination of Hu PGRPs in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu PGRPs.
Accession number
O75594
Dose range
6.14-1500 pg/ml
Sensitivity of the dosage
6 pg/ml
Calibration range
6 pg/ml to 1.500 pg/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
Kit ELISA sandwich PGRPs/PGLYRP1 (human): quantitative determination of Hu PGRPs in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu PGRPs.
Kit ELISA sandwich PGRPs/PGLYRP1 (human): quantitative determination of Hu PGRPs in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu PGRPs.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
Primary immune recognition is based on common structures among invasive pathogens. Bacterial surface molecules, such as lipopolysaccharide (LPS) and peptidoglycan (PGN), cause immune reactions ranging from cytokine release to fever. Recently, a family of proteins called peptidoglycan recognition protein (PGRP) has been identified in mice and humans that bind to peptidoglycans expressed on Gram-positive bacteria. Peptidoglycan (PGN) is an essential component of the cell wall of virtually all bacteria (1.2) and therefore is an excellent target for recognition by the eucaryotic innate immune system. PPRGs (PPRG-L, PPRG-S, PPRG-Ia and PPRG-Ib) define a new family of human pattern recognition molecules (3). PGRP-L is primarily expressed in the liver. Although the liver is not considered to be a primary immune organ, the liver participates in host defenses by producing acute phase proteins (by hepatocytes) in response to infections and eliminating micro-organisms from the blood (4). PGRP-S is present in neutrophils and inhibits the growth of Gram-positive bacteria and can therefore function as a neutrophil antibacterial protein (5). However, PGRP-S may have another function, which is still unidentified, because in humans it is expressed in the bone marrow 50-100 times higher than in neutrophils.